This federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 10, 2024 with a ceiling value of $20,466.17. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 11, 2024. There is no set-aside...
This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 3, 2024. The contract is a firm fixed-price delivery order with a ceiling value of $2,482.56 and a completion date of July 5, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 26, 2024, with a ceiling value of $1,055.16. The contract is a Firm Fixed Price Delivery Order, with a period of performance through February 27, 2024. There is no set-aside designation for this...
This federal contract award is for the delivery of lidocaine 5% patches to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $3,367.16. The contract is a delivery order with a firm fixed-price pricing type and an ultimate completion date of July 19, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of Lidocaine 5% Patches, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 28, 2024 with a ceiling value of $1,870.47 and a completion date of May 29, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Lidocaine 5% Patch 30s medical products to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on May 21, 2024, with a ceiling value of $2,666.94. The contract is a delivery order with a firm fixed price, and the ultimate completion date is May 22, 2024. This contract is not a set-aside award....
This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $6,305.62, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 29, 2025 and is structured as a Firm Fixed Price Delivery Order. The contract does not have a set-aside designation,...
This federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price type, valued at $7,192.91, and has an ultimate completion date of October 13, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract, valued at $4,973.90, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is October 28, 2024. This award is not associated with a set-aside designation,...
This contract award is for the supply of Lidocaine 5% patches to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 20, 2024, with a ceiling value of $1,334.51 and an ultimate completion date of May 21, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...